These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28089387)

  • 1. Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
    Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
    Urol Oncol; 2017 May; 35(5):250-256. PubMed ID: 28089387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
    Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
    Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.
    Wong AT; Safdieh JJ; Rineer J; Weiner J; Schwartz D; Schreiber D
    Int Urol Nephrol; 2015 Oct; 47(10):1629-34. PubMed ID: 26329748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.
    Borno HT; Lichtensztajn DY; Gomez SL; Palmer NR; Ryan CJ
    Cancer; 2019 Feb; 125(3):453-462. PubMed ID: 30444526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
    Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
    Cabo J; Shu X; Shu XO; Parikh A; Bailey C
    J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Surveillance for Men with Intermediate Risk Prostate Cancer.
    Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H
    J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities associated with advanced prostate cancer stage at diagnosis.
    Marlow NM; Halpern MT; Pavluck AL; Ward EM; Chen AY
    J Health Care Poor Underserved; 2010 Feb; 21(1):112-31. PubMed ID: 20173259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
    Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR; Mahal BA; Nguyen PL; Yu JB
    Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013.
    Ramirez E; Morano J; Beguiristain T; Castro G; de la Vega PR; Nieder AM; Barengo NC
    Cancer Epidemiol; 2019 Apr; 59():104-108. PubMed ID: 30731402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease.
    Price JT; Zimmerman LD; Koelper NC; Sammel MD; Lee S; Butts SF
    Am J Obstet Gynecol; 2017 Nov; 217(5):572.e1-572.e10. PubMed ID: 28784416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate Cancer.
    Liu W; Goodman M; Filson CP
    JAMA Netw Open; 2020 Oct; 3(10):e2015198. PubMed ID: 33026448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance and racial differences in long-term acute care utilization after critical illness.
    Lane-Fall MB; Iwashyna TJ; Cooke CR; Benson NM; Kahn JM
    Crit Care Med; 2012 Apr; 40(4):1143-9. PubMed ID: 22020247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
    Fedewa SA; Lerro C; Chase D; Ward EM
    Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
    Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
    Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
    Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot-assisted versus open radical prostatectomy utilization in hospitals offering robotics.
    Yanamadala S; Chung BI; Hernandez-Boussard TM
    Can J Urol; 2016 Jun; 23(3):8279-84. PubMed ID: 27347621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.